Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

U.S. patent awarded for Sertoli cell transplants

March 12, 1998

Bone Care International submits NDA for oral one-alpha D2

March 11, 1998

Polydex receives continuing funding for contraceptive research

March 11, 1998

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Lilly expands product options for Ligand

March 11, 1998

New ACAT-inhibitory malondiamido derivatives from Sanwa

March 10, 1998

First approval for RPR's new combination patch

March 10, 1998

Antithromboxane therapy leads to clinical benefit in type II diabetics

March 9, 1998

Droxia approved by FDA for sickle cell anemia

March 6, 1998

Mechanism of insulinotropic action of BTS-67582 explored in B-cells

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...